Statistics for Treatment of exudative age-related macular degeneration with intravitreal ranibizumab in clinical practice: a 3-year follow-up
Total visits
| views | |
|---|---|
| Treatment of exudative age-related macular degeneration with intravitreal ranibizumab in clinical practice: a 3-year follow-up | 94 |
Total visits per month
| views | |
|---|---|
| September 2024 | 3 |
| October 2024 | 14 |
| November 2024 | 7 |
| December 2024 | 8 |
| January 2025 | 0 |
| February 2025 | 0 |
| March 2025 | 0 |
File Visits
| views | |
|---|---|
| Treatment of Exudative Age-Related Macular.pdf(legacy) | 162 |
| Treatment of Exudative Age-Related Macular.pdf | 6 |
Top country views
| views | |
|---|---|
| United States | 44 |
| China | 15 |
| Australia | 12 |
| Mongolia | 5 |
| India | 4 |
| Canada | 2 |
| Portugal | 2 |
| Ukraine | 2 |
| Argentina | 1 |
| Brazil | 1 |
| Germany | 1 |
| United Kingdom | 1 |
| Ireland | 1 |
| Italy | 1 |
| Russia | 1 |